NASDAQ:SLGL - Nasdaq - IL0011417206 - Common Stock - Currency: USD
NASDAQ:SLGL (6/2/2025, 8:00:02 PM)
7.24
+0.03 (+0.42%)
The current stock price of SLGL is 7.24 USD. In the past month the price decreased by -0.82%. In the past year, price decreased by -11.01%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
LLY | ELI LILLY & CO | 54.3 | 708.08B | ||
JNJ | JOHNSON & JOHNSON | 15.46 | 373.90B | ||
NVO | NOVO-NORDISK A/S-SPONS ADR | 20.23 | 323.61B | ||
NVS | NOVARTIS AG-SPONSORED ADR | 14.04 | 230.49B | ||
AZN | ASTRAZENECA PLC-SPONS ADR | 16.35 | 223.01B | ||
MRK | MERCK & CO. INC. | 9.79 | 191.47B | ||
PFE | PFIZER INC | 7.31 | 133.38B | ||
SNY | SANOFI-ADR | 11.05 | 119.71B | ||
BMY | BRISTOL-MYERS SQUIBB CO | 6.65 | 99.29B | ||
GSK | GSK PLC-SPON ADR | 9.36 | 84.51B | ||
ZTS | ZOETIS INC | 28.14 | 75.43B | ||
HLN | HALEON PLC-ADR | 23.29 | 51.37B |
Sol-Gel Technologies Ltd. operates as a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. The firm is focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The Company’s offers a range of products twins, sirs-t, and vered. The firm is designed its proprietary, silica-based microencapsulation technology platform to enhance the tolerability and stability of topical drugs while maintaining their efficacy. Topical drugs often struggle to balance achieving both high efficacy and high tolerability. Its technology platform entraps active ingredients in an inert, inorganic silica shell, which creates an unnoticeable barrier between the active ingredient and the skin.
SOL-GEL TECHNOLOGIES LTD
Golda Meir 7
Ness Ziona 7403648 IL
CEO: Alon Seri-Levy
Employees: 36
Phone: 97289313433
The current stock price of SLGL is 7.24 USD. The price increased by 0.42% in the last trading session.
The exchange symbol of SOL-GEL TECHNOLOGIES LTD is SLGL and it is listed on the Nasdaq exchange.
SLGL stock is listed on the Nasdaq exchange.
SOL-GEL TECHNOLOGIES LTD (SLGL) has a market capitalization of 20.20M USD. This makes SLGL a Nano Cap stock.
SOL-GEL TECHNOLOGIES LTD (SLGL) currently has 36 employees.
SOL-GEL TECHNOLOGIES LTD (SLGL) has a support level at 7.2 and a resistance level at 7.86. Check the full technical report for a detailed analysis of SLGL support and resistance levels.
The Revenue of SOL-GEL TECHNOLOGIES LTD (SLGL) is expected to decline by -42.11% in the next year. Check the estimates tab for more information on the SLGL EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
SLGL does not pay a dividend.
SOL-GEL TECHNOLOGIES LTD (SLGL) will report earnings on 2025-08-14.
SOL-GEL TECHNOLOGIES LTD (SLGL) does not have a PE ratio as the earnings reported over the last twelve months were negative (-3.79).
ChartMill assigns a technical rating of 6 / 10 to SLGL. When comparing the yearly performance of all stocks, SLGL is one of the better performing stocks in the market, outperforming 73.36% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to SLGL. No worries on liquidiy or solvency for SLGL as it has an excellent financial health rating, but there are worries on the profitability.
Over the last trailing twelve months SLGL reported a non-GAAP Earnings per Share(EPS) of -3.79. The EPS increased by 62.91% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -29.52% | ||
ROE | -36.67% | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 83% to SLGL. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of -42.86% and a revenue growth -42.11% for SLGL